Deeptech MSV

Deeptech MSV, often identified with Main Sequence Ventures (MSV) and its 'Deep Tech Adventures' newsletter, is a pivotal force in Australia's deep tech ecosystem. Main Sequence Ventures is an Australian deep tech investment fund, established in 2017 by the country's national science agency, CSIRO. The firm is dedicated to backing founders who leverage scientific and engineering breakthroughs to create globally impactful companies. Its mission extends beyond mere capital investment, aiming to bridge the critical gap between groundbreaking scientific discovery and its successful commercial deployment. This approach underpins their commitment to fostering new industries and solving some of humanity's most pressing challenges.

Main Sequence Ventures differentiates itself through its 'venture science' model, which combines the operational agility of startups with the profound curiosity of Australia's research sector. This unique methodology allows them to systematically reduce risks and amplify opportunities for deep tech companies. They provide 'patient capital' to support innovations that often require longer research and development cycles than traditional tech ventures, such as AI, quantum computing, robotics, advanced materials, biotechnology, and clean energy. Their portfolio reflects a commitment to addressing global challenges like decarbonisation, food security, healthcare, and industrial productivity.

Since its inception, Main Sequence Ventures has achieved significant milestones, notably surpassing $1 billion in total funds under management within six years. The firm has backed 53 companies, which have collectively generated over 2,100 new jobs, and whose market value has grown to over $AU6.8 billion. Key investments include companies like Q-CTRL (quantum control software), Gilmour Space (private space launch), Emesent (autonomous underground drones), and V2food (plant-based meat). These achievements underscore their role in transforming Australia's innovation landscape.

The firm actively nurtures the deep tech community through various initiatives, including the 'Atmosphere' platform, designed to support early-stage deep tech startups with initial funding, tailored mentorship, and access to crucial networks and expertise. The 'Deep Tech Adventures' newsletter serves as a vital communication channel, sharing news, insights, and job opportunities within the deep tech sector. Leadership at Main Sequence Ventures comprises experienced partners such as Phil Morle, Mike Zimmerman, and Martin Duursma, who bring extensive backgrounds in venture capital, entrepreneurship, and scientific commercialisation.

Main Sequence Ventures' impact extends to strengthening the link between academia and industry, serving as a blueprint for how science agencies can partner with venture capital to build next-generation industries. They are instrumental in equipping researchers with the knowledge and support needed to translate their discoveries into fundable deep tech companies. Through their strategic investments and ecosystem-building efforts, Deeptech MSV, through Main Sequence Ventures, is helping to position Australia at the forefront of global deep tech innovation.